Extracelluar matrix metalloproteinase as a novel target for pancreatic cancer therapy
作者： Sharon Samuel , Nemil Shah , Emily E. Helman , Joseph A. Knowles , Cecil R. Stockard
DOI: 10.1097/CAD.0B013E328349311E
关键词: Metalloproteinase 、 Matrix metalloproteinase 、 Pancreatic cancer 、 Radioimmunoassay 、 Gene Knockdown Techniques 、 Gene knockdown 、 Extracellular matrix 、 Pancreatic tumor 、 Pathology 、 Biology 、 Pharmacology (medical) 、 Cancer research 、 Oncology 、 Pharmacology
摘要: The objective of this study was to evaluate extracellular matrix metalloproteinase (EMMPRIN) as a novel target in orthotopic pancreatic cancer murine models. MIA PaCa-2 human tumor cells were implanted groups 1 and 3–7, whereas EMMPRIN knockdown group
sci-hub.se 参考文章(50)
H.H Fiebig, A Maier, A.M Burger, Clonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery. European Journal of Cancer. ,vol. 40, pp. 802- 820 ,(2004) , 10.1016/J.EJCA.2004.01.009
Stéphanie Caudroy, Myriam Polette, Béatrice Nawrocki-Raby, Jian Cao, Bryan P. Toole, Stanley Zucker, Philippe Birembaut, EMMPRIN-mediated MMP regulation in tumor and endothelial cells. Clinical & Experimental Metastasis. ,vol. 19, pp. 697- 702 ,(2002) , 10.1023/A:1021350718226
Albert B Seymour, Ralph H Hruban, Mark Redston, Carlos Caldas, Steve M Powell, Kenneth W Kinzler, Charles J Yeo, Scott E Kern, None, Allelotype of Pancreatic Adenocarcinoma Cancer Research. ,vol. 54, pp. 2761- 2764 ,(1994)
A. Lewis Farr, Oliver H. Lowry, Rose J. Randall, Nira J. Rosebrough, Protein Measurement with the Folin Phenol Reagent Journal of Biological Chemistry. ,vol. 193, pp. 265- 275 ,(1951)
T. Conroy, F. Desseigne, M. Ychou, M. Ducreux, O. Bouche, R. Guimbaud, Y. Becouarn, C. Montoto-Grillot, S. Gourgou-Bourgade, A. Adenis, , Randomized phase III trial comparing FOLFIRINOX (F: 5FU/leucovorin [LV], irinotecan [I], and oxaliplatin [O]) versus gemcitabine (G) as first-line treatment for metastatic pancreatic adenocarcinoma (MPA): Preplanned interim analysis results of the PRODIGE 4/ACCORD 11 trial. Journal of Clinical Oncology. ,vol. 28, pp. 4010- 4010 ,(2010) , 10.1200/JCO.2010.28.15_SUPPL.4010
Wenyue Zhang, Lynn M Matrisian, Kenn Holmbeck, Catherine C Vick, Eben L Rosenthal, Fibroblast-derived MT1-MMP promotes tumor progression in vitro and in vivo BMC Cancer. ,vol. 6, pp. 52- 52 ,(2006) , 10.1186/1471-2407-6-52
H A Burris, M J Moore, J Andersen, M R Green, M L Rothenberg, M R Modiano, M C Cripps, R K Portenoy, A M Storniolo, P Tarassoff, R Nelson, F A Dorr, C D Stephens, D D Von Hoff, Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. Journal of Clinical Oncology. ,vol. 15, pp. 2403- 2413 ,(1997) , 10.1200/JCO.1997.15.6.2403
Faten Bougatef, Suzanne Menashi, Farah Khayati, Benyoussef Naïmi, Raphaël Porcher, Marie-Pierre Podgorniak, Guy Millot, Anne Janin, Fabien Calvo, Céleste Lebbé, Samia Mourah, EMMPRIN promotes melanoma cells malignant properties through a HIF-2alpha mediated up-regulation of VEGF-receptor-2. PLOS ONE. ,vol. 5, ,(2010) , 10.1371/JOURNAL.PONE.0012265
Curtis J. Wray, Syed A. Ahmad, Jeffrey B. Matthews, Andrew M. Lowy, Surgery for Pancreatic Cancer: Recent Controversies and Current Practice Gastroenterology. ,vol. 128, pp. 1626- 1641 ,(2005) , 10.1053/J.GASTRO.2005.03.035
Bradford A. Moffat, Thomas L. Chenevert, Charles R. Meyer, Paul E. Mckeever, Daniel E. Hall, Benjamin A. Hoff, Timothy D. Johnson, Alnawaz Rehemtulla, Brian D. Ross, The Functional Diffusion Map: An Imaging Biomarker for the Early Prediction of Cancer Treatment Outcome Neoplasia. ,vol. 8, pp. 259- 267 ,(2006) , 10.1593/NEO.05844